Creyos

If it's not in the EHR, it won't scale.

When cognitive assessment results sit in a separate platform, they rarely make it into documentation, care coordination, or population-level reporting.

That's why we built Creyos to integrate directly into Epic.

🏥 In-clinic assessments launch from existing workflows during routine visits
💻 Remote assessments reach patients through MyChart ahead of appointments
📋 Results and reports flow into the patient chart automatically

No new logins, no manual entry, no switching between systems.

For health systems on Epic, cognitive data sits where the rest of the clinical record already does.

Read the full article: https://hubs.li/Q04klPyT0

Millions of Medicare Advantage members are living with undiagnosed cognitive conditions.

Every month of delayed detection compounds clinical harm, distorts risk accuracy, and drives avoidable cost deeper into full-risk contracts.

Claremedica recognized that traditional screening couldn't keep pace. They pivoted to digital cognitive assessment before the gap became unmanageable.

Tomorrow, join Dr. Nehal Gheewala (Claremedica Chief Medical Officer), Benjamin Todd (Claremedica SVP, Strategy & Analytics), and Erin Smith (Creyos Chief Marketing Officer) for a free RISE webinar on:
➡️ How they built the urgency case internally
➡️ What changed on the ground for clinicians and patients
➡️ What full-risk leaders should be doing differently now

📅 June 4 · 1:30 PM EDT

Register here: https://hubs.li/Q04k0nLp0

📍 At Becker's 16th Annual Meeting in Chicago, discussions about dementia care had moved from exploration to infrastructure.

This year it wasn't about whether health systems should invest in cognitive health. It was about how to build programs, scale them across systems, and make the finances work. Speakers from major health systems described care models for dementia that mirror how those same systems already approach cancer care.

Catriona Galbraith, Creyos Strategic Accounts Director, recaps what stood out and what it means for cognitive health strategy:

https://hubs.li/Q04jRfW90

💬 The right service, in the right place, at the right time.

Our CEO Marc Lipton heard versions of that framing at industry conferences and executive roundtables in the first half of this year, from payer executives, system CMOs, and primary care leaders.

For cognitive health, the gap between that aspiration and what happens in primary care today is measurable. And it's an infrastructure problem, not an awareness one.

Read Marc's reflection on the Creyos blog: https://hubs.ly/Q04j68j-0

One thing that’s become clear across brain health conversations this year:

Earlier detection of cognitive decline only matters if it’s practical to implement — especially in already strained healthcare environments.

✈️ This week at APG Spring in San Diego, Creyos Chief Marketing Officer Erin Smith will be connecting with healthcare leaders to discuss what scalable cognitive assessment actually looks like in practice — for clinicians, patients, and care systems alike.

We're looking forward to conversations around population health, value-based care, and the future of accessible cognitive assessment.

📍 We're excited to return to the Millennium Alliance Healthcare Providers Transformation Assembly in Miami, June 2–3!

Jamie Zuckier, Faraz Shafaghi, and Marc Lipton will be on-site and looking forward to connecting with Healthcare leaders from across the U.S.

🧠 Mild cognitive impairment is both common and surprisingly underdetected, particularly in primary care settings where formal cognitive testing often isn't part of the workflow at all.

In a new NeurologyLive interview, Creyos Chief Scientific Officer Adrian Owen, PhD, OBE, discusses the research behind the Creyos Dementia Screener.

Built using machine learning, the screener is designed to flag early signs of cognitive decline in minutes, without requiring specialist training to administer.

Read the full interview: https://hubs.li/Q04hb7P40

🧠 The AAN Annual Meeting covered a lot of ground. Alzheimer's biomarkers, cognitive care in neurodiverse populations, menopausal brain fog, medication-related impairment.

For our team, one theme stood out across all of it: whether cognitive measurement is keeping pace with what the field needs from it.

Creyos Staff Scientist Sydni Paleczny shares her reflections from the meeting.

🔍 Read her full recap on the Creyos blog: https://hubs.li/Q04gNH4K0

🧠 Creyos cognitive tasks provide objective measures of different areas of cognition.

The four domains measured:
🟦 Short-term memory
🟩 Reasoning
🟨 Concentration
🟪 Verbal ability

Each task gathers domain-specific data in minutes, either remotely or in person. Used alongside behavioral health questionnaires within the platform, they give clinicians a fuller picture of a patient's neuropsychological symptoms.

This article on the Creyos blog walks through each task, what it measures, and the clinical context behind it: https://hubs.li/Q04gHSGh0

🧠 98% of neurologists now use telehealth in some capacity.

From telestroke consults to multiple sclerosis monitoring to epilepsy management, virtual visits are reshaping how neurologists deliver care. The bigger question is how practices are adapting their diagnostic workflows to keep up.

This article covers where telemedicine is proving most effective in neurology, and how practices are streamlining everything from follow-ups to cognitive assessment.

Read more: https://hubs.li/Q04fYZ7V0